Homocysteine, vitamins B6, B12, folate, and risk of coronary artery disease in patients undergoing diagnostic coronary angiography

被引:9
作者
Abdelmouttaleb, I
Danchin, N
Aimone-Gastin, I
Namour, F
Angioi, M
Gelot, MA
Bennani, N
Lambert, D
Jeandel, C
Guéant, JL
机构
[1] Univ Hosp Ctr Nancy, Lab Cellular & Mol Pathol Nutr, EP CNRS 616, Vandoeuvre Nancy, France
[2] Univ Hosp Ctr Nancy, Dept Cardiol, Vandoeuvre Nancy, France
[3] Univ Hosp Ctr Nancy, Dept Internal Med, Vandoeuvre Nancy, France
[4] Univ Hosp Ctr Nancy, INSERM, U308, Vandoeuvre Nancy, France
[5] Univ Hosp Ctr Nancy, Biochem Lab, Vandoeuvre Nancy, France
关键词
amino acids; homocysteine; vitamin B12; vitamin B6; folates; coronary artery disease;
D O I
10.1007/s007260050012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Homocysteine and vitamins B were correlated with coronary artery disease in patients undergoing diagnostic coronary angiography. 160 patients having greater than or equal to 1 stenosis (G1), 55 patients having normal coronary arteries (G2) and 171 healthy volunteers (G3) were prospectively recruited. Homocysteine levels were significantly higher in patients, particulary in those with normal coronary angiograms, than in healthy subjects (13.8 +/- 6.3 mu mol/L in G1 (p < 0.0001) and 15.2 +/- 8.8 mu mol/L in G2 (p < 0.0001) versus 10.1 +/- 3.1 mu mol/L in G3). Homocysteine levels were not related to the extent of coronary artery disease. In patients with normal angiogram, vitamin B12 and folate levels were significantly higher compared with the other groups (p < 0.05 and p < 0.001, respectively) showing that vitamin B deficiency was not involved in the hyperhomocysteinemia. In conclusion, homocysteine and vitamins B levels do not contribute to discriminate for the presence of coronary artery disease in patients undergoing diagnostic coronary angiography. Homocysteine levels, however, were higher in patients referred for coronary angiography than in healthy controls.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 35 条
[1]   RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[2]   DETERMINATION OF HOMOCYSTEINE IN PLASMA BY ION-EXCHANGE CHROMATOGRAPHY [J].
ANDERSSON, A ;
BRATTSTROM, L ;
ISAKSSON, A ;
ISRAELSSON, B ;
HULTBERG, B .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1989, 49 (05) :445-449
[3]   IMPAIRED HOMOCYSTEINE METABOLISM - A RISK FACTOR IN YOUNG-ADULTS WITH ATHEROSCLEROTIC ARTERIAL OCCLUSIVE DISEASE OF THE LEG [J].
ARONSON, DC ;
ONKENHOUT, W ;
RABEN, AMTJ ;
OUDENHOVEN, LFIJ ;
BROMMER, EJP ;
VANBOCKEL, JH .
BRITISH JOURNAL OF SURGERY, 1994, 81 (08) :1114-1118
[4]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[5]   HIGHER TOTAL PLASMA HOMOCYSTEINE IN VITAMIN-B12 DEFICIENCY THAN IN HETEROZYGOSITY FOR HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
LINDGARDE, F ;
HULTBERG, B .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (02) :175-178
[6]   Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease [J].
Christensen, B ;
Frosst, P ;
LussierCacan, S ;
Selhub, J ;
Goyette, P ;
Rosenblatt, DS ;
Genest, J ;
Rozen, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :569-573
[7]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[8]  
DALY LE, 1995, IRISH J MED SCI S15, V164, P6
[9]   DISORDERED METHIONINE HOMOCYSTEINE METABOLISM IN PREMATURE VASCULAR-DISEASE - ITS OCCURRENCE, COFACTOR THERAPY, AND ENZYMOLOGY [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
WANG, J ;
LYNCH, JF ;
MACEY, D ;
LUNDBERG, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (09) :1253-1260
[10]  
ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142